Παρακολούθηση
Pawel Buszman
Pawel Buszman
Medical University of Silesia
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ka.onet.pl
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute …
Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ...
European heart journal 32 (23), 2999-3054, 2011
49662011
Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Authors/Task Force Members, K Fox, MAA Garcia, D Ardissino, ...
European heart journal 27 (11), 1341-1381, 2006
21782006
Everolimus-eluting stents or bypass surgery for left main coronary artery disease
GW Stone, JF Sabik, PW Serruys, CA Simonton, P Généreux, J Puskas, ...
New England Journal of Medicine 375 (23), 2223-2235, 2016
11372016
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
S Windecker, PW Serruys, S Wandel, P Buszman, S Trznadel, A Linke, ...
The Lancet 372 (9644), 1163-1173, 2008
7782008
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
PW Serruys, S Silber, S Garg, RJ van Geuns, G Richardt, PE Buszman, ...
New England journal of medicine 363 (2), 136-146, 2010
7592010
Five-year outcomes after PCI or CABG for left main coronary disease
GW Stone, AP Kappetein, JF Sabik, SJ Pocock, MC Morice, J Puskas, ...
New England Journal of Medicine 381 (19), 1820-1830, 2019
6832019
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy …
P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ...
The Lancet 392 (10151), 940-949, 2018
6752018
Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
PW Serruys, HM García-García, P Buszman, P Erne, S Verheye, ...
Circulation 118 (11), 1172-1182, 2008
659*2008
Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left …
M Tendera, W Wojakowski, W Rużyłło, L Chojnowska, C Kępka, W Tracz, ...
European heart journal 30 (11), 1313-1321, 2009
5472009
Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization
PE Buszman, SR Kiesz, A Bochenek, E Peszek-Przybyla, I Szkrobka, ...
Journal of the American College of Cardiology 51 (5), 538-545, 2008
5022008
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS …
GG Stefanini, B Kalesan, PW Serruys, D Heg, P Buszman, A Linke, ...
The Lancet 378 (9807), 1940-1948, 2011
4072011
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in …
PW Serruys, V Farooq, B Kalesan, T De Vries, P Buszman, A Linke, ...
JACC: Cardiovascular Interventions 6 (8), 777-789, 2013
3632013
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
J Escaned, C Collet, N Ryan, G Luigi De Maria, S Walsh, M Sabate, ...
European heart journal 38 (42), 3124-3134, 2017
3032017
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial
JJ Wykrzykowska, S Garg, C Girasis, T De Vries, MA Morel, GA Van Es, ...
Journal of the American College of Cardiology 56 (4), 272-277, 2010
2832010
Mobilization of Bone Marrow-Derived Oct-4+ SSEA-4+ Very Small Embryonic-Like Stem Cells in Patients With Acute Myocardial Infarction
W Wojakowski, M Tendera, M Kucia, E Zuba-Surma, E Paczkowska, ...
Journal of the American College of Cardiology 53 (1), 1-9, 2009
2832009
Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the …
V Džavík, CE Buller, GA Lamas, JM Rankin, GBJ Mancini, WJ Cantor, ...
Circulation 114 (23), 2449-2457, 2006
2222006
4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A …
M Taniwaki, GG Stefanini, S Silber, G Richardt, P Vranckx, PW Serruys, ...
Journal of the American College of Cardiology 63 (16), 1617-1625, 2014
1932014
Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry
PE Buszman, PP Buszman, RS Kiesz, A Bochenek, B Trela, ...
Journal of the American College of Cardiology 54 (16), 1500-1511, 2009
1812009
Drug-eluting stent for left main coronary artery disease: the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass …
A Chieffo, E Meliga, A Latib, SJ Park, Y Onuma, P Capranzano, ...
JACC: Cardiovascular Interventions 5 (7), 718-727, 2012
1722012
Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (left main coronary artery stenting) LE MANS trial
PE Buszman, PP Buszman, I Banasiewicz-Szkróbka, KP Milewski, ...
Cardiovascular Interventions 9 (4), 318-327, 2016
1652016
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20